Special Issue "Breast Cancer Survivors and Supportive Therapies"
A special issue of Cancers (ISSN 2072-6694).
Deadline for manuscript submissions: 31 October 2023 | Viewed by 3258
Special Issue Editors
Interests: breast surgery; integrative oncology; microbiome in cancer (oncobiotic); supportive therapies; complementary treatments; quality of life
Interests: breast surgery; integrative oncology; microbiome in cancer (oncobiotic); supportive therapies; complementary treatments; quality of life
Special Issue Information
Dear Colleagues,
Breast cancer is, in most cases, a curable disease and not as life-threatening as it was in the past, thanks to early diagnosis and advances in oncological treatments. As a result of the huge prevalence of this disease, together with this improvement in its prognosis, a wider and wider population of breast cancer survivors often face multiple and long-lasting side effects related to anticancer therapies, that could be prevented, alleviated, or cured if properly assessed and managed. In other terms, the outstanding advances in survival have not been matched so far by a comparable commitment to preserving the quality of life of long-term survivors. A new holistic, evidence-based approach is therefore needed, focused on providing cancer patients with the best available oncological treatments alongside person-centered support since the diagnosis of cancer, is based on behaviors (nutrition, physical activity, sleep), psychosocial aspects, and sexual and spiritual issues.
Trying to assess and manage these clinical needs, by integrating mainstream and complementary treatments, will allow breast cancer patients to achieve the goal of complete healing and rehabilitation, in order not just to survive their cancer, but to thrive beyond it.
Dr. Stefano Magno
Dr. Antonio Franco
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- quality of life
- integrative oncology
- side effects
- unmet needs
- complementary treatments
- nutrition in oncology
- exercise oncology
- sexual issues in cancer patients
- oncofertility
- acupuncture